Investment, Funding & Disinvestments
-
MSD acquires Cidara Therapeutics for USD9.2B to strengthen influenza prevention pipeline
The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).
-
GE HealthCare acquires Intelerad for USD2.3B to expand cloud-based imaging solutions
The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.
-
Rwanda launches construction of new veterinary lab to end dependence on overseas sample testing
This new facility will replace the existing laboratory, which Minister of Agriculture and Animal Resources Mark Cyubahiro Bagabe noted has served for nearly four decades and no longer meets current needs.
-
Merck KGaA enters USD3B AI drug discovery partnership with Valo Health to target Parkinson’s disease
Through this partnership, Merck gains access to Valo’s advanced AI-powered human causal biology and discovery platforms, which the drugmaker will use to identify new disease targets and develop preclinical compounds.
-
AstraZeneca commits USD2B to expand Maryland manufacturing operations
The new facility will produce molecules for medical trials. These expansions will create 200 additional jobs in Frederick and 100 more in Gaithersburg.